↓ Skip to main content

Bone metabolism in anorexia nervosa: molecular pathways and current treatment modalities

Overview of attention for article published in Osteoporosis International, August 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users

Citations

dimensions_citation
29 Dimensions

Readers on

mendeley
84 Mendeley
Title
Bone metabolism in anorexia nervosa: molecular pathways and current treatment modalities
Published in
Osteoporosis International, August 2012
DOI 10.1007/s00198-012-2095-6
Pubmed ID
Authors

D. J. Howgate, S. M. Graham, A. Leonidou, N. Korres, E. Tsiridis, E. Tsapakis

Abstract

Eating disorders are associated with a multitude of metabolic abnormalities which are known to adversely affect bone metabolism and structure. We aimed to comprehensively review the literature on the effects of eating disorders, particularly anorexia nervosa (AN), on bone metabolism, bone mineral density (BMD), and fracture incidence. Furthermore, we aimed to highlight the risk factors and potential management strategies for patients with eating disorders and low BMD. We searched the MEDLINE/OVID (1950-July 2011) and EMBASE (1980-July 2011) databases, focussing on in vitro and in vivo studies of the effects of eating disorders on bone metabolism, bone mineral density, and fracture incidence. Low levels of estrogen, testosterone, dehydroepiandrosterone, insulin-like growth factor-1 (IGF-1), and leptin, and high levels of cortisol, ghrelin, and peptide YY (PYY) are thought to contribute to the 'uncoupling' of bone turnover in patients with active AN, leading to increased bone resorption in comparison to bone formation. Over time, this results in a high prevalence and profound degree of site-specific BMD loss in women with AN, thereby increasing fracture risk. Weight recovery and increasing BMI positively correlate with levels of IGF-1 and leptin, normalisation in the levels of cortisol, as well as markers of bone formation and resorption in both adolescent and adult patients with AN. The only treatments which have shown promise in reversing the BMD loss associated with AN include: physiologic dose transdermal and oral estrogen, recombinant human IGF-1 alone or in combination with the oral contraceptive pill, and bisphosphonate therapy.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 84 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Unknown 83 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 14 17%
Student > Bachelor 13 15%
Student > Ph. D. Student 9 11%
Student > Doctoral Student 7 8%
Researcher 6 7%
Other 21 25%
Unknown 14 17%
Readers by discipline Count As %
Medicine and Dentistry 32 38%
Biochemistry, Genetics and Molecular Biology 6 7%
Psychology 6 7%
Nursing and Health Professions 5 6%
Sports and Recreations 5 6%
Other 14 17%
Unknown 16 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 February 2013.
All research outputs
#14,730,916
of 22,673,450 outputs
Outputs from Osteoporosis International
#2,205
of 3,596 outputs
Outputs of similar age
#102,886
of 166,798 outputs
Outputs of similar age from Osteoporosis International
#22
of 40 outputs
Altmetric has tracked 22,673,450 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,596 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one is in the 35th percentile – i.e., 35% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 166,798 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 36th percentile – i.e., 36% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 40 others from the same source and published within six weeks on either side of this one. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.